| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Common Stock, par value $0.01 per share |
16% |
$37,859,003 |
+$1,192,086 |
30,046,828 |
+3.3% |
Rubric Capital Management LP |
15 Oct 2025 |
| IART |
Integra Lifesciences Holdings Corporation |
Common Stock, par value $0.01 per share |
9.5% |
$90,232,770 |
+$33,254,915 |
7,353,934 |
+58% |
Rubric Capital Management LP |
30 Jun 2025 |
| COLL |
Collegium Pharmaceutical, Inc. |
Common Stock, $0.001 par value |
9.3% |
$80,340,000 |
+$17,407,000 |
3,000,000 |
+28% |
Rubric Capital Management LP |
31 Mar 2025 |
| KNSA |
Kiniksa Pharmaceuticals International, plc |
Class A Ordinary Shares, nominal value $0.000273235 per share |
9.2% |
$108,181,595 |
+$14,569,740 |
3,909,806 |
+16% |
RUBRIC CAPITAL MANAGEMENT LP |
30 Jun 2025 |
| ECVT |
Ecovyst Inc. |
Common Stock, par value $0.01 per share |
9.1% |
$91,104,000 |
|
10,400,000 |
|
Rubric Capital Management LP |
30 Sep 2025 |
| NFE |
New Fortress Energy Inc. |
Class A Common Stock, par value $0.01 |
8.9% |
$140,190,768 |
+$53,790,768 |
24,338,675 |
+62% |
Rubric Capital Management LP |
31 Mar 2025 |
| GLNG |
Golar LNG Limited |
Common Shares, $1.00 par value per share |
8.6% |
$360,531,735 |
+$50,812,559 |
8,975,149 |
+16% |
Rubric Capital Management LP |
31 Mar 2025 |
| TLN |
Talen Energy Corporation |
Common Stock, $0.001 par value per share |
7.9% |
$1,532,291,500 |
-$384,173,865 |
3,602,171 |
-20% |
David Rosen |
30 Sep 2025 |
| SDGR |
Schrodinger, Inc. |
Common Stock, $0.01 par value |
7.8% |
$128,750,000 |
|
5,000,000 |
|
Rubric Capital Management LP |
31 Dec 2024 |
| TRVI |
Trevi Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
7.1% |
$42,659,300 |
+$21,633,655 |
8,531,860 |
+103% |
Rubric Capital Management LP |
30 Jun 2025 |
| QDEL |
QuidelOrtho Corporation |
Common Stock, par value $0.001 per share |
6.9% |
$133,660,537 |
-$26,291,573 |
4,637,738 |
-16% |
Rubric Capital Management LP |
30 Jun 2025 |
| OPK |
OPKO Health, Inc. |
Common Stock, par value $0.01 per share |
6% |
$63,137,011 |
|
47,791,243 |
|
Rubric Capital Management LP |
30 Jun 2025 |
| TAC |
TransAlta Corporation |
Common Shares, no par value |
5.4% |
$170,734,525 |
|
15,948,151 |
|
Rubric Capital Management LP |
30 Jun 2025 |
| CHRS |
Coherus BioSciences, Inc. |
Common Stock, $0.0001 par value |
4.6% |
$5,258,754 |
|
5,258,754 |
|
Rubric Capital Management LP |
31 Dec 2024 |
| SEG |
Seaport Entertainment Group Inc. |
Common Stock, par value $0.01 |
4.5% |
$11,118,381 |
|
573,408 |
|
Rubric Capital Management LP |
31 Dec 2024 |
| DOLE |
Dole Plc |
Ordinary Shares, $0.01 par value per share |
4.4% |
$62,085,501 |
|
4,155,656 |
|
Rubric Capital Management LP |
31 Mar 2025 |
| ADPT |
Adaptive Biotechnologies Corporation |
Common stock, par value $0.0001 per share |
4.1% |
$72,889,139 |
|
6,256,847 |
|
Rubric Capital Management LP |
30 Jun 2025 |
| MD |
Pediatrix Medical Group, Inc. |
Common Stock, $0.01 par value |
3.7% |
$38,914,718 |
|
3,148,440 |
|
Rubric Capital Management LP |
31 Dec 2024 |
| OVID |
Ovid Therapeutics Inc. |
Common Stock, par value $0.001 per share |
0.67% |
$153,131 |
|
478,533 |
|
Rubric Capital Management LP |
30 Jun 2025 |
| GDRX |
GoodRx Holdings, Inc. |
Class A Common Stock, $0.0001 par value |
0% |
$0 |
-$27,862,214 |
0 |
-100% |
Rubric Capital Management LP |
31 Mar 2025 |